# Elastic Type: Company (ESTC) Source: GetYourBrief — https://getyourbrief.com/entity/elastic Canonical HTML page: https://getyourbrief.com/entity/elastic ## Timeline - **2026-07-15**: Test results published — AV-Comparatives released its Business Security Test results, revealing top performers and key insights. - **2026-06**: AV-Comparatives test period ends — Conclusion of the March-June 2026 Business Security Test. - **2026-05**: Foxconn data theft — Foxconn confirmed that the Nitrogen ransomware group stole approximately 8 terabytes of data from its North American factories. - **2026-03**: Stryker breach — Iranian-linked hackers breached Stryker, triggering mass factory resets on more than 200,000 devices across 79 countries, halting operations. - **2026-03**: AV-Comparatives test period begins — Start of the Business Security Test evaluating 16 endpoint security products against real-world threats. ## Recent coverage (9 stories, network-wide) ### Elastic Drops 4.4% as Morgan Stanley Slashes Price Target to $66 2026-08-11 00:52:22 · Sector: saas · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Elastic shares fell after Morgan Stanley downgraded the stock, citing slower-than-expected AI-driven search growth and rising competition from Palo Alto Networks, CrowdStrike, and Datadog. The price target was cut 9.6% to $66, highlighting concerns that the SaaS company’s search AI pivot is not delivering revenue acceleration quickly enough. Full story: https://getsaasbrief.com/story/elastic-estc-morgan-stanley-downgrade-ai-search-growth-lags ### 99.8% Real-World Protection: AV-Comparatives Ranks 16 Endpoint Security Products 2026-08-01 08:33:13 · Sector: cyber · Sentiment: Positive · Impact: 6/10 · Sources: 2 Independent testing of 16 business endpoint security products reveals Kaspersky, Bitdefender, and Elastic blocked 99.8% of live attacks, while Elastic scored a perfect 100% in malware detection. The results come amid high-profile breaches at Stryker and Foxconn that exploited weak endpoints. Full story: https://getcyberbrief.com/story/av-comparatives-endpoint-security-test-2026 ### SaaS Stocks Surge as AI Rotation Fuels 4.3% ServiceNow Gain 2026-07-20 14:04:43 · Sector: saas · Sentiment: Positive · Impact: 6/10 · Sources: 1 Investors rotated from chips to oversold enterprise software on July 13, 2026, sending SaaS stocks higher. ServiceNow jumped 4.3% and Salesforce rose 2.4%, powered by renewed confidence in AI monetization after the SaaSpocalypse. The shift signals a new phase where application-layer SaaS becomes the AI control point. Full story: https://getsaasbrief.com/story/saas-stocks-surge-ai-rotation ### Elastic and CRA International Lead High-Stakes Q4 Earnings Window 2026-02-25 05:13:54 · Sector: saas · Sentiment: Neutral · Impact: 5/10 · Sources: 5 A diverse group of industry leaders, including search giant Elastic and consulting firm CRA International, are set to report Q4 results on February 26. The upcoming disclosures will provide critical insights into enterprise AI adoption and the health of professional services in a shifting macroeconomic environment. Full story: https://getsaasbrief.com/story/elastic-crai-q4-earnings-preview-2026 ### Q4 Earnings Preview: Consumer Resilience and AI Integration in Focus 2026-02-25 05:13:14 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 5 A diverse group of mid-to-large cap companies across consumer staples, healthcare, and tech are set to report Q4 results tomorrow. Investors are looking for signs of margin expansion amid stabilizing inflation and the impact of generative AI on software demand. Full story: https://getfinancebrief.com/story/q4-earnings-preview-sjm-estc-vtrs-xpof-crai ### Viatris and CRA International Set for Q4 Earnings Amid Pharma Shifts 2026-02-25 05:12:42 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 5 Viatris (VTRS) and CRA International (CRAI) are scheduled to report Q4 results on February 26, 2026, providing critical insights into the generic drug market and life sciences consulting demand. These reports come as the industry faces significant regulatory and pricing headwinds from the Inflation Reduction Act and a shifting biosimilar landscape. Full story: https://getbiobrief.com/story/viatris-crai-q4-earnings-pharma-analysis ### Retail and Discretionary Spending in Focus Ahead of Q4 Earnings Slate 2026-02-25 05:12:38 · Sector: retail · Sentiment: Neutral · Impact: 5/10 · Sources: 5 A diverse group of companies, including J.M. Smucker and Xponential Fitness, are set to report Q4 earnings on February 26, 2026. These reports will provide critical insights into consumer spending patterns across staples, boutique fitness, and enterprise search technology. Full story: https://getretailbrief.com/story/retail-discretionary-earnings-preview-sjm-xpof-estc ### Viatris and CRA International Set for Q4 Earnings Amid Healthcare Shifts 2026-02-25 05:12:04 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 5 Viatris and CRA International are scheduled to report Q4 results tomorrow, providing critical insights into the generic pharmaceutical landscape and life sciences consulting demand. These reports come as the industry grapples with pricing pressures, regulatory shifts, and a stabilizing post-pandemic consulting market. Full story: https://gethealthbrief.com/story/viatris-cra-international-q4-earnings-preview ### Guggenheim Reaffirms Bullish Stance on SaaS Leaders Workday and Elastic 2026-02-19 16:41:27 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Guggenheim Securities has maintained its 'Buy' ratings for Workday and Elastic, signaling confidence in the enterprise software sector's resilience. The analyst's move underscores the strategic importance of AI integration and recurring revenue models in the current market environment. Full story: https://getfinancebrief.com/story/guggenheim-reiterates-buy-workday-elastic-saas-outlook --- This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.